Chiral Quest has opened up a production facility near Shanghai in
China, to tap into the trend by pharmaceutical companies to site
manufacturing operations in the region, writes Phil Taylor.
Chiral Quest parent VioQuest Pharmaceuticals has been awarded a US
patent covering the use of novel catalysts to increase the
efficiency of chiral amine and amino acid synthesis.
Catalyst company Chiral Quest has launched a new product,
C3-TunePhos, designed for use in the synthesis of a range of drugs,
including the cholesterol-lowering statin class.
Chiral Quest has forged an alliance with DSM to accelerate the
take-up of its catalysis products, used in the synthesis of
chemicals and pharmaceuticals.
Life science company Chiral Quest this week announced that the
non-profit organisation, the Penn State Research Foundation, has
received a US patent covering the compositions of matter and use
for a series of chiral phosphine ligands...
